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Introduction
The epidemiology of  respiratory disease in rural Malawi 
is largely unknown.  Published studies have concentrated 
on the most prevalent diseases causing admission to 
hospital in urban areas.  An important exception to 
this rule is the large body of  published literature on 
tuberculosis in children and adults.  The purpose of  this 
article is to review what is known about infectious and 
non-infectious respiratory disease in children and adults, 
and to highlight the important questions that require new 
studies to provide answers.  In each section, infectious 
and non-infectious respiratory disease will be considered 
in turn as illustrated in Table 1.  Published literature was 
searched using Pubmed searches of  the term “Malawi” 
(269 hits), “Africa and lung”(697 hits), and by consultation 
with local specialists.  Grey literature was sought through 
the Documentation Center of  the Ministry of  Health, the 
UN Resource Center, the College of  Medicine “Malawiana 
collection” and by contacting the Health Management 
Information Unit of  the Ministry of  Health.
Distribution of  disease
Distribution of  Infectious Respiratory Disease in 
Children
Acute Respiratory Infection
Acute respiratory infection (ARI) includes upper and 
lower respiratory tract infections and the incidence and 
prevalence	of 	ARI	are	therefore	dependent	on	definition.	
Upper respiratory tract infections are far more common 
than pneumonia (or lower respiratory tract infections) but 
almost all ARI-related mortality is due to pneumonia.  A 
cohort study of  infants in rural Malawi found an average 
of  1.1 episodes of  ARI per year with a peak incidence in 
infants aged 1-3 months and during the cool season.1 The 
incidence is likely to be higher in infants living in urban 
areas. Ministry of  Health data given in Table 2 report 
case	rates	in	under-fives	for	all	ARI	combined.	A	higher	
number of  pneumonia cases was reported from February 
to April but numbers of  reported cases of  pneumonia 
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when based on clinical criteria alone are likely to be 
affected by the clinical overlap with malaria.2 
Pneumonia among hospitalized children in Malawi has 
been studied recently in the context of  the Malawi Child 
Lung Health Project which ran from 2000 to 2004 as a joint 
project between International Union Against Tuberculosis 
and Lung Disease (IUATLD) and the Ministry of  Health.3 
Around 4 000 cases of  severe or very severe pneumonia were 
treated annually in 24 of  the 25 government hospitals in 
Malawi.	The	importance	of 	case	definition	is	emphasized	
by the discrepancy with the much higher incidence rates 
as reported in the 2005 Health Management Information 
Service (HMIS) bulletin which included non-severe as well 
as severe pneumonia. Between July 2004 and June 2005, 
624,000 new pneumonia cases were diagnosed in children 
under	five	years	old	in	government	and	CHAM	(Christian	
Health Association of  Malawi) hospitals, representing 
298	 cases/1000	 population	 [Health	 Management	
Information Bulletin. Annual Report. Ministry of  Health 
and	 Population,	 Lilongwe,	 2005].	 This	 may	 still	 be	 an	
underestimate as the 2000 Demographic Health Survey 
found that 7.1% of  children presented to a health facility 
for	 treatment	when	 the	 child	 had	ARI	 as	 defined	 by	 a	
history of  cough and fast breathing in the two weeks 
before the survey, which is equivalent to 1850 cases/1000 
per year.
Tuberculosis
Tuberculosis (TB) among children in Malawi has been 
described.4  In 1998, there were 2739 cases of  TB 
registered in children (11.9% of  the national reported 
cases).  The estimated rates of  TB in children were 
78/100,000 in children under one year, 83/100 000 in 
children aged 1 to 4 years and 33/100 000 in those aged 
5-14 years.  In this study, central hospitals and mission 
hospitals reported higher rates of  childhood TB than 
district hospitals.  There is no contact tracing of  adult 
cases of  TB in most of  Malawi, but the rates of  childhood 
TB estimated in this study were thought to be accurate as 
they are consistent with rates measured in other parts of  
Africa, and have increased from previous estimates from 
the pre-HIV era.5
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HIV related infections
Pneumonia is the most common cause of  morbidity and 
mortality in HIV-infected children.6  HIV infection of  
children alters the pattern of  respiratory illness.6,7,8  HIV 
causes increased bacterial pneumonia and tuberculosis, 
but also Pneumocystis pneumonia (PcP) and a chronic 
lung disease, probably of  infective origin, known as 
lymphocytic interstitial pneumonitis (LIP).9,10  The 
incidence and severity of  bacterial pneumonia in HIV 
infected children in Africa are known to be greater than 
in non-HIV infected children11	but	exact	figures	are	not	
known in Malawi.  In a cohort study in Blantyre from birth 
until 3 years, the frequency of  cough and pneumonia was 
significantly	higher	in	HIV-infected	children	compared	to	
non HIV-infected children.12   
Distribution of  Infectious Respiratory Disease in 
Adults
Tuberculosis
The Malawi National Tuberculosis Programme (NTP) 
has collected data for many years and documented an 
increase in the total number of  cases as the burden of  HIV 
has increased.  There were 28,234 cases of  tuberculosis 
treated in 2003 and 7716 (27%) were sputum smear-
positive.  Using tuberculin test reactivity in unvaccinated 
6 year olds to estimate the annual risk of  infection and 
population statistics, the NTP has estimated that these 
figures	 represent	 46%	 of 	 tuberculosis	 cases	 in	 Malawi	
and a incident rate of  81/100 000 per year.  Many of  
the remainder will be treated outside the 44 hospitals 
registering cases, mostly in small private hospitals and 
clinics.
TB cases show a peak incident age of  25-34 years, and no 
gender difference.  Increases in the prevalence of  HIV 
have increased the incidence of  TB cases; the percentage 
of  cases of  TB attributable to HIV has risen from 17% to 
57% in Karonga, with the increase in women occurring at 
a younger age (15-29 yrs) than in men (30-44 yrs).13
Pneumonia 
Respiratory tract infections and fever have been described 
as the most common cause of  admission to hospital 
in Malawi even in the pre-HIV era.14,15  In Botswana in 
1997, pneumonia caused 8.3% of  in-patient deaths (TB 
caused 15.7%).16 Six hundred cases of  acute pneumonia 
are now admitted to the adult medical wards of  Queen 
Elizabeth Central Hospital (QECH), Blantyre, each year 
in a unit that admits approximately 10,000 patients per 
year but there has been no detailed diagnostic study of  
the aetiology of  these infections.
HIV related infections including empyema
A recent cohort study of  660 HIV-infected Malawian 
adults following strict diagnostic criteria reported 
incidence rates of  3.8 per 100 person years of  observation 
(pyo)	 for	 confirmed	 bacterial	 pneumonia;	 16.5	 per	 100	
pyo for probable bacterial pneumonia; 12.1 per 100 pyo 
for	 pulmonary	 TB	 and	 0.6	 per	 100	 pyo	 for	 confirmed	
PcP.17
The seroprevalence of  HIV infection among hospital 
inpatients at QECH, Blantyre is 70% on medical wards 
and 45% on surgical wards.  Pneumonia cases have an 
HIV seroprevalence of  approximately 75%, but cases with 
pneumococcal bacteraemia have an HIV seroprevalence 
of  5%.18  In studies of  352 patients with a presumptive 
diagnosis of  sputum negative tuberculosis, 17 cases of  
PCP were diagnosed by bronchoscopy and BAL.19  Non-
typhoidal Salmonella (NTS) infections are common in 
patients presenting with cough, but this is thought to be 
due to dual infections with NTS and a typical respiratory 
pathogen such as Streptococcus pneumoniae  in patients with 
late HIV.20  Approximately 20 cases of  empyema are seen 
in the central hospitals per year – most are HIV positive.
Bronchitis	
There has been no survey of  bronchitis in Malawi but 
cases have been reported.u  In South Africa, the national 
incidence	 of 	 bronchitis	 defined	 as	 chronic	 productive	
cough is 2.3% in men and 2.8% in women.v  
Distribution of  non infectious respiratory disease in 
children
HIV related tumours
Kaposi’s sarcoma (KS) is the most common HIV related 
malignancy in Malawian children (EM Molyneux, personal 
communication). Pulmonary KS does occur in children 
and is usually associated with palatal KS and bloody 
pleural effusion. Pulmonary lymphoma is rare.  
Asthma
Asthma is treated in a small number of  children in the 
central hospitals in Malawi, but is an uncommon disease 
(approx 0.6% of  cases admitted to hospital). It is likely 
to be more common in children from relatively wealthy, 
urban-based families23,w, and in Malawi these children will 
present to private practitioners.  Misdiagnosis has been 
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appreciated as a problem in other parts of  Africa. 25  
Cystic fibrosis 
There	has	not	been	a	confirmed	case	of 	cystic	fibrosis	in	
Malawi.
Distribution of  non infectious respiratory disease in 
adults 
HIV related tumours (Kaposi’s sarcoma)
Atypical African Kaposi’s sarcoma is associated with 
AIDS.z  The incidence of  pulmonary Kaposi’s sarcoma 
in Malawi could be estimated by the association of  palatal 
KS in patients with either blood stained pleural effusion 
or progressive pulmonary symptoms unresponsive to 
antibiotics and TB treatment but no such study has been 
reported.  Kaposi’s sarcoma remains the most common 
malignancy diagnosed in medical wards in Malawi. A 
recent cohort study of  HIV-infected adults in Blantyre 
found an incidence rate of  5 cases of  KS per 100 pyo.17 
In a Zimbabwean series of  48 pulmonary KS cases, 
second diagnoses (eg concurrent TB) were uncommon 
and prognosis was poor.27
Chronic obstructive pulmonary disease 
The global burden of  disease caused by chronic 
obstructive lung disease secondary to cigarette smoking is 
well	known,	but	is	not	yet	a	significant	problem	in	Malawi.	
The burden of  COPD caused by indoor air pollution 
due to cooking with smoky fuel is becoming appreciated 
globally	and	is	 likely	to	be	a	significant	problem	among	
women in Malawi.  There has been no detailed survey in 
Malawi, but a study in Nigeria showed an association of  
COPD with biomass fuel use in women.28
In a recent study of  128 volunteer adults carrying out 
FEV1 assessments in Blantyre, the mean percent predicted 
FEV1 among women was 72% compared to 86% in 
men.  The presence of  a low percent predicted FEV1 
was associated with female gender, biomass fuel use, 
tuberculosis and HIV status but not cigarette smoking 
(Gordon SB, unpublished data).  
Cor pulmonale
Cor pulmonale is common in late middle aged women 
presenting as medical outpatients.  There has been no 
study of  the association of  this presentation with biomass 
fuel use.  Heart failure secondary to lung disease has been 
reported in Nigeria.29
Tobacco related disease
Tobacco is the most important cash crop in Malawi.  Local 
consumption of  tobacco is by inhalation of  snuff, and by 
smoking in cigarettes.  Cigarette smoking in women is 
unusual, and in men rarely exceeds 5 cigarettes per day. 
The burden of  disease attributable to tobacco use has 
not been assessed.  COPD is likely to be associated with 
biomass fuel use and a history of  tuberculosis.  Bronchial 
carcinoma is seen but is unusual due to the relatively small 
number of  smokers and the low life expectancy among 
Malawians.
Asthma	
Severe asthma is an uncommon presentation to hospital.21 
In Botswana, asthma and COPD caused 0.7% of  inpatient 
deaths where tuberculosis (15.6) and pneumonia (8.3%) 
were common.  
Occupational lung disease
The important industries in Malawi where occupational 
lung disease might be expected are the cotton industry, 
including	dyeing	of 	cloth,	 the	tobacco	 industry,	fishing,	
small bakeries and the processing of  tea and coffee. 
There are no published data from these industries.
Malawians have traditionally travelled within the region 
to	find	work	 in	 the	mines	of 	South	Africa.	 	 It	 is	 likely	
that occupational lung disease will have occurred in these 
migrant workers30,31, but no data regarding the burden of  
this disease are available.
Sarcoid, pulmonary fibrosis	 	 	
There are no published data on the incidence of  
inflammatory	or	fibrosing	lung	disease	in	Malawi.		In	the	
current HIV epidemic, chronic lung disease almost always 
occurs in the context of  HIV infection and is presumed 
to be due to chronic infection.
TB is the only respiratory disease for which there 
are good incidence and prevalence data in Malawi
Pneumonia is a major cause of  hospital admission 
and death in children
The burden of  disease due to pneumonia in adults 
is high but the causes are unknown
Pneumonia and TB are the most common causes 
of  morbidity and mortality in HIV-infected adults 
and children
The burden of  disease due to COPD is likely to be 
highly due to biomass fuel use and tuberculosis
1.
2.
3.
4.
5.
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Distribution of  determinants for respiratory disease 
Determinants of  Respiratory Disease in Children
The important determinants of  respiratory disease in 
children are often common to the major diseases described 
above and often inter-linked.  These determinants, which 
can either increase or decrease the incidence of  disease, are 
divided into biological, behavioural and social categories. 
Biological determinants include malnutrition, age, HIV 
infection,	 Vitamin	 A	 deficiency	 and	 concomitant	 viral	
infections.  Behavioural determinants include vaccination 
status, biomass fuel use, alcohol abuse and cigarette 
smoking.  Social determinants include crowding and the 
number of  siblings.
Biological determinants of  respiratory disease in children
Young age is a major factor that increases the incidence, 
severity and mortality associated with pneumonia in 
childhood. Low birth weight, protein-energy malnutrition 
and	micronutrient	(vitamin	A	&	zinc)	deficiency	are	also	
important determinants of  incidence and severity of  ARI 
and are common.  Around one-third of  babies are born 
with	 low	 birth	 weight	 (<2.5	 kg)	 and	 21%	 of 	 children	
were	recorded	as	underweight	in	HMIS	figures	from	2003	
(regional range 8-68%).  
Viral infections are common and increase mucosal 
inflammation	 and	 increase	 the	 incidence	 of 	 bacterial	
pneumonia.  The reduction in viral infective episodes 
following the pneumococcal conjugate vaccine trial 
in South Africa has been used to illustrate the role 
of  secondary bacterial infection in exacerbating the 
symptoms of  primary viral infection.32  
HIV infection is an important determinant of  pneumonia 
and of  non-infectious pulmonary disease such as LIP 
and pulmonary KS.  The overall HIV seroprevalence in 
paediatric admissions at QECH in Blantyre is 18.9%33 but 
over 50% for acute and chronic pneumonia.8,10  The vast 
majority of  children infected with HIV are infected by 
vertical transmission; on average 20% of  women attending 
antenatal clinic are HIV infected countrywide.34  Vertical 
transmission of  HIV can be reduced using peri-partum 
anti-retroviral therapy35 and single-agent nevirapine is 
now offered to mothers delivering in hospital in Malawi. 
The major risk factors for development of  HIV related 
infections are falling CD4 count and rising viral load.36 
Malnutrition is an additional risk factor for severe 
infections in HIV infected children.
Breast feeding is protective against ARI in childhood but 
does increase the risk of  vertical transmission of  HIV. 
The current recommendation in Malawi is that women 
should breast feed exclusively if  possible, regardless of  
HIV status.  
Biological determinants of  respiratory disease in adults
The biological determinants of  respiratory disease in 
adults are similar to those in children with young age being 
replaced by old age and chronic disease.  The traditional 
risks for pneumonia and tuberculosis of  poverty, advanced 
age, and malnutrition have been overtaken in Malawi by 
HIV which is now the single most important risk factor 
for disease and has caused the incidence of  TB to rise 
despite an effective NTP.13,37  French has estimated that 
the proportion of  bacterial pneumonia attributable to 
HIV in sub-Saharan Africa is approximately 73% based 
on community acquired pneumonia (CAP) rates in HIV 
infected and uninfected cohorts in the region.38   The 
incidence of  bacterial pneumonia in patients on treatment 
for TB is much higher in HIV infected than non-HIV-
infected patients and so the incidence of  dual infections 
has increased.39  In addition, a study in Kenya has shown 
that 8% of  community acquired pneumonia in adults is 
due to TB.40 The major risk factor for bronchitis in South 
Africa is a history of  tuberculosis.41  
HIV infection is also a determinant of  non-infectious 
respiratory disease.  KS is associated with advanced HIV 
disease and co-infection with Human Herpes Virus 8 
(HHV-8).  HHV-8 viraemia is common in HIV clinic 
attendees42, and associated with high anti-HHV-8 IgG43 
in southern Africa, but no study of  risk factors has been 
reported in Malawi.  Lymphoma is also associated with 
HIV infection, but no study has been carried out in 
Malawi.44
Biological determinants of  respiratory disease that are 
important elsewhere in the world such as very advanced 
age, nursing home residence, chronic diseases (liver or 
renal	failure,	diabetes)	and	steroid	use	are	not	significant	
in Malawi.  
Behavioural determinants of  respiratory disease in 
children
Good vaccination coverage has been associated with a 
reduction in ARI-related deaths in Malawian children 
especially of  measles and pertussis and now possibly 
bacterial	 pneumonia	 due	 to	Haemophilus	 influenzae	 as	
well.  Biomass fuel use has been shown to be associated 
with increased ARI in children in Zimbabwe45 and coal 
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smoke exposure is associated with bronchitis in China.46 
This has not been described in Malawi but conditions are 
similar and the effect is likely to be the same.  Maternal 
cigarette smoking is extremely rare in Malawi, and cigarette 
smoking in men is relatively light, so this is not likely to be 
a current risk factor for ARI in Malawian children.
Behavioural determinants of  respiratory disease in adults
The behavioural determinants of  respiratory disease 
that are likely to be important in Malawian adults are 
alcohol abuse, cigarette smoking, and the use of  biomass 
fuel.  Studies of  these determinants have not yet been 
published.   
Male gender is associated with tobacco use in Malawi 
(as in South Africa47) and knowledge about health risks 
are limited in either gender.48  Since the prevalence of  
tobacco-related disease is not known, the importance 
of  this observation remains in question.  There is 
substantial variation in genetic susceptibility to tobacco-
related disease, particularly COPD and bronchial cancer, 
in populations where tobacco use is heavy.49  It is likely 
that migrant worker effects contribute to the burden of  
tobacco related disease in Malawi by the known synergistic 
effect of  asbestosis.50,51
In unpublished data, the use of  biomass fuel for cooking 
was associated with lower FEV1 values in women and 
with respiratory symptoms (Gordon, 2004). Cigarette 
smoking in men, and smoky cooking fuel in women are 
significantly	 associated	with	 chronic	 cough	 in	 southern	
Africa	therefore	bronchitis	is	likely	to	be	a	significant	but	
unrecognised problem in Malawi.52  Further, clinicians in 
Malawi report that severe heart failure in late middle-aged 
women with lung disease (cor pulmonale) is a common 
presentation and suspect that this relates to the use of  
biomass fuel (J Kumwenda, personal communication).
Social determinants of  respiratory disease in children
Crowding and the number of  siblings in a family (more 
siblings present an increased risk) are associated with 
ARI and TB in children world-wide.  Improved housing 
has been shown to improve children’s health in northern 
Malawi.53  Exposure to an index case is a major risk 
factor for TB, and active contact tracing found nine 
times more TB cases than passive contact tracing in 
Malawi.  The current resource-constrained lack of  active 
contact tracing is therefore a risk factor for tuberculosis 
in Malawian children.54  Children are at particular risk 
of  TB when the household contact is female (especially 
the mother) and sputum smear-positive (SM Graham, 
personal communication).
The major risk factors for the development of  asthma 
in children are being studied in other parts of  Africa 
where wheezing is common.55,56,57  Factors associated with 
urban living, such as lack of  domestic animals, cooking 
with kerosene and increased exposure to house dust mite 
seem	 to	be	 important.	 	These	findings	make	 it	unlikely	
that there will be a dramatic increase in the prevalence of  
childhood asthma in Malawi in the near future.
Social determinants of  respiratory disease in adults
Special risk groups for tuberculosis in Malawi include 
prisoners58, prison employees, health care personnel and 
ex-miners.bg  Groups at special risk of  bacterial pneumonia 
are migrant workers in the South African mines but this 
risk is incurred at the mining barracks and not in Malawi. 
Occupational exposures in cement factories, bakeries, 
fish	 processing	 plants	 and	 other	 industries	 may	 be	 an	
under-appreciated problem but the major industry in 
Malawi is the tobacco industry.  Dust-related symptoms 
are likely as have been shown elsewhere.60  Workers in the 
tobacco industry are exposed to high dust levels in drying 
flues	and	when	stacking	the	dried	leaf.		This	results	in	a	
restrictive lung defect independent of  cigarette smoking.61 
In addition, a large number of  tobacco workers in 
Zimbabwe smoke unprocessed leaf  and are at increased 
risk of  bronchial carcinoma.62  The same is likely to be 
true in Malawi.  Symptoms of  occupational asthma were 
reported in the cotton industry in Malawi but with the 
decline of  this industry these have become rare.  Asthma 
in adults is rare in Malawi and likely to remain so due to 
the environmental constraints outlined above.
Impact of  the disease
Health impact of  infectious Respiratory Disease in 
Age and nutritional status are important determi-
nants for respiratory disease
HIV infection is now the major risk factor associ-
ated with infectious and non-infectious respiratory 
disease in children and adults in Malawi
Biomass fuel use is an under recognised threat to 
respiratory heath, particularly in women, and should 
be further investigated
Childhood immunization is important in preventing 
infectious causes of  severe pneumonia 	
1.
2.
3.
4.
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Children
Acute Respiratory Infection
Respiratory disease is estimated to cause 20% of  deaths 
in children under 5 in Africa63, where many countries 
still report an under-5 mortality of  between 10 and 20% 
of  all births.64  The Malawi Child Lung Health Project 
found that case-fatality rates for children hospitalized 
with severe pneumonia prior to implementation of  the 
project ranged from 8 to 29% in district hospitals.  The 
majority of  deaths are due to bacterial pneumonia, PcP 
and TB.65  
Tuberculosis
Tuberculosis is under-diagnosed in children66 but 
outcomes are poor even in those in whom treatment is 
initiated.  Only 45% of  children completed treatment 
with 17% dying, 13% defaulting and 21% lost to follow-
up.  Outcome was worst in younger children, and children 
with sputum negative TB.  Approximately 1200 children 
die per year of  TB in Malawi.4
HIV related infections
Children with HIV are at greater risk of  recurrent disease 
and death. The majority of  children in Malawi infected 
with HIV die by 3 years of  age and pneumonia is the 
main cause of  death.7   A study of  severe pneumonia 
at QECH found an overall case-fatality rate of  22% and 
was	significantly	higher	for	HIV-infected	children	(30%)	
compared to HIV-uninfected children (9%).10 
Health impact of  Infectious Respiratory Disease 
in Adults
Tuberculosis
TB cases have approximately a 20% mortality before the 
end	of 	 treatment,	with	figures	being	worse	 for	 sputum	
negative and extra-pulmonary infection.  In a study of  
ambulatory TB therapy, 33% of  patients died by 12 
months, with death associated with older age, HIV 
infection and parenchymal lung disease.67   The NTP 
estimates that the registered cases of  TB (28,000 per year) 
are 45% of  the actual cases.  If  20% die during treatment, 
this equates to 12,500 deaths per year attributable to 
TB.  If  one third of  cases die by 12 months, this equates 
to approximately 20,000 deaths per year.   The loss of  
income and daily function in tuberculosis patients is 
dramatic and has recently been described by Mann and 
colleagues (publication pending). 
Pneumonia
Approximately 600 cases of  pneumonia are admitted to 
QECH, Blantyre, each year and the case fatality rate in 
this group is 19%.  French has estimated that the number 
of  cases of  adult pneumonia in Malawi is approximately 
51,000 per year.  The mortality due to community acquired 
pneumonia (CAP) in Malawi may approximate to 10,000 
deaths per year, of  which 70% will be HIV associated.
HIV related infections
Cohorts of  HIV infected adults not receiving anti-
retroviral therapy have a mortality rate per year of  up 
to 25%.17,68  Most of  this mortality relates to death from 
HIV associated infections.  Cohort and hospital-based 
cross-sectional studies have found that the predominant 
bacterial infections in HIV-infected Malawian adults are 
NTS and S. pneumoniae.17,69
Bronchitis	
The health impact of  bronchitis in Malawi probably results 
in many days taken off  work, but no data are available.
Non infectious respiratory disease in children
HIV related tumours
Pulmonary KS is rapidly fatal.  
Asthma
Rare cause of  death but individual morbidity considerable 
because of  limited treatment options.
Non infectious respiratory disease in adults 
HIV related tumours (Kaposi’s sarcoma)
A case series from southern Africa found that median 
survival for KS even with chemotherapy was only 70 
days.27
Chronic obstructive pulmonary disease
The burden and severity of  this disease in Malawi is not 
known.
Cor pulmonale
The burden and severity of  this disease in Malawi is not 
known, but untreated survival in severe heart failure is 
typically less than 6 months.
Tobacco related disease
There are no relevant data from Malawi.
Asthma 
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The health impact of  asthma in affected persons will be 
severe, as very little inhaled therapy is available and so 
guideline directed control70 of  symptoms is impossible.
Occupational lung disease
No data.
Effective interventions
Interventions, like determinants, can be divided into 
biological, behavioural and social categories.  
Biological interventions to improve respiratory 
health in children
The need for improved nutrition of  Malawian children 
is self-evident and beyond the remit of  this chapter. 
Education and improved antenatal care of  mothers to 
reduce the high proportion of  low birth-weight babies 
would also be effective. Vitamin A is routinely given at 6 
months of  age in Malawi and community-based studies 
in Tanzania and elsewhere found that this is protective 
against measles-related mortality. Therapeutic doses of  
vitamin A are very effective in reducing pneumonia-
related death in children with measles71 but only 20% of  
the expected number of  vitamin A doses were given in 
2003 (HMIS Bulletin Dec 2003). Zinc may also have a 
role in reducing pneumonia-related deaths.72
Vaccination is an effective intervention for many 
infectious diseases including causes of  pneumonia 
and the current WHO Extended Programme of  
Immunisation (EPI) in Malawi includes BCG, 
diphtheria, pertussis, tetanus, measles and more 
recently	(since	2002)	Haemophilus	influenzae	type	b	
(Hib)	conjugate	vaccine.		Preliminary	findings	form	
the 2004 Demographic Health Survey found that 64% 
of  children received all vaccinations – 91% received 
BCG and 78% received measles.  A conjugate vaccine 
was effective against 9 capsular types of  Streptococcus 
pneumoniae73 in South Africa, but this vaccine is 
prohibitively expensive for Malawi, and the serotype 
coverage is not ideal anyway.74  Nevertheless, there is no 
prospect of  a better vaccine in the next 10 years, and the 
effect of  herd immunity in the USA was twice that of  
the direct vaccination effect.  The Pneumo-Accelerated  
Development and Introduction Programme (Pneumo 
ADIP: www.preventpneumo.org) www. programme 
sponsored by the Global Alliance for Vaccines and 
Immunisation (GAVI:www.vaccinealliance.org)  is 
therefore giving consideration to the implementation of  
pneumococcal conjugate vaccines in the least wealthy 
nations.  
BCG vaccination reduces severe disease due to tuberculosis 
and is preventive against leprosy75, but can cause disease 
in HIV infected children.76	 	 	 The	 benefit	 of 	 providing	
isoniazid preventive therapy to young well childhood 
contacts of  cases of  smear-positive TB is potentially large 
but uncertain.54,77
Reduction of  maternal and perinatal HIV infection is 
possible, and has the potential to dramatically reduce 
HIV related lung disease by halving the number of  HIV 
infected children (see AIDS chapter).  ART became freely 
available under the National AIDS Commission managed 
ART programme in 2004 to treat a limited number of  HIV 
infected children.  ART reduces infections and prolongs 
survival in HIV infected children.  Cotrimoxazole 
prophylaxis given to all HIV-exposed infants is effective 
in preventing PcP infection and a recent study in Zambian 
children over 1 year old found that it improved survival, 
reduced hospitalizations and pneumonia-related deaths.78 
Cotrimoxazole prophylaxis is now recommended in 
HIV infected children in Malawi in line with WHO 
recommendations based on the Zambian study (http://
www.who.int/3by5/en).  EPI immunizations are usually 
effective in HIV-infected children albeit with reduced 
efficacy	compared	to	HIV-uninfected	children.	
Biological interventions to improve respiratory 
health in adults
The NTP in Malawi will not be effective unless TB 
control is combined with an ART strategy.13,79,80  There is 
likely	negligible	benefit	of 	neonatal	BCG	preventing	adult	
disease. M.vaccae has been tested as an adjuvant treatment 
in	 Karonga	 District	 and	 Zambia	 without	 benefit.81 
Prevention of  pneumonia in adults by vaccination is not 
yet an achievable goal.  The 23-valent pneumococcal 
polysaccharide vaccine is effective in preventing invasive 
pneumococcal disease in western populations but did 
not help HIV infected Ugandan adults.68  There is a 
The burden of  respiratory infection in Malawi is 
huge:
about 12500 adults and 1200 children die each 
year from TB
Pneumonia is estimated to cause 20% of  all under 
five	mortality
The health impact of  respiratory disease due to 
biomass fuel use and tobacco is not known
1.
a.
b.
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possibility that the herd effect of  the 7-valent conjugate 
vaccine would reduce the burden of  adult pneumonia 
but this has not yet been tested in an area of  high HIV 
seroprevalence.  
Isoniazid preventive therapy82 and cotrimoxazole 
prophylaxis have both been shown to reduce infections 
in HIV infected adults.83,84  In Malawi, cotrimoxazole 
prophylaxis has been shown to reduce mortality in HIV-
infected tuberculosis patients in Karonga and Thyolo 
districts.85  Cotrimoxazole prophylaxis is now being rolled 
out as part of  the HIV/TB care package in Malawi but 
supply will present a major challenge.  
ART is effective in reversing some cutaneous Kaposi’s 
sarcoma and there are reports of  some successful 
palliation of  peripheral KS with single agent vincristine 
but in pulmonary KS this success is unusual.    
Behavioural interventions to improve respiratory 
health in children
An intervention study showing an alternative to biomass 
fuel use that resulted in less ARI or respiratory symptoms 
in children has not yet been achieved in Malawi.  Studies 
in India86 and Guatemala87,88 are ongoing but regional 
differences will be critical in determining if  interventions 
will be effective.
Behavioural interventions to improve respiratory 
health in adults
Cessation of  cigarette smoking and good management of  
intercurrent infections can reduce the rate of  deterioration 
of  COPD induced by cigarette smoking.  It is not clear 
if  reduced exposure to biomass fuel smoke will have any 
beneficial	 effect	 –	 it	 is	 more	 likely	 that	 prevention	 of 	
damage	will	be	the	primary	benefit.
Social interventions to improve respiratory health in 
children
The Malawi Child Lung Health Project tested the 
hypothesis that treatment outcomes in ARI could 
be improved by education of  health givers and by the 
reliable provision of  antibiotics.  The study was successful 
reducing pneumonia case-fatality rates by as much as 40% 
in district hospitals and much of  the success was due to 
provision of  oxygen and antibiotics. The Project will 
report in 2006 and is now including CHAM hospitals. 
The widespread implementation of  contact tracing54 might 
reduce the health burden of  tuberculosis in children in 
Malawi89 but would require a substantial increase in public 
awareness and would need to be supported by increased 
accuracy of  diagnosis of  tuberculosis in children.90  These 
approaches are not currently available in Malawi due to 
resource limitations.
Social interventions to improve respiratory health in 
adults
Smoke related health effects are dose-dependent and 
partially reversible on removal of  the exposure.  Prevention 
or alleviation of  bronchitis in Malawi can only follow 
identification	of 	the	problem	and	specific	risk	factors.		If 	
biomass	fuel	use	was	shown	to	have	a	significant	health	
impact in Malawi, the abundant provision of  hydro-
electric power might improve health and increase forest 
resources at the same time.
Removal of  provoking agents and effective therapy give 
good control of  asthma symptoms and avoid deaths. 
Asthma is not high enough on the burden of  disease 
list to be given much resource at present.  Adequate 
management of  heart failure relieves symptoms and 
domiciliary oxygen prolong life in cor pulmonale.  ACE 
inhibitors and other effective drugs are a limited resource 
in Malawi where even basic hospital resources cannot 
be sustained and domiciliary oxygen is unrealistic. 
Fortunately, the prevalence of  cor pulmonale is low.
Advocacy to change political will, legislation and taxation 
can alter tobacco production and consumption.  Unless 
these changes are implemented in Malawi, a legacy 
of  tobacco related disease is likely.  Even if  Malawian 
tobacco production is reduced, legislation must be put in 
place to protect Malawians from the predatory marketing 
practices of  the cigarette manufacturers that have caused 
controversy in the USA and Turkey.  The announcement in 
February 2005 that Malawi will not ratify the Framework 
Convention on Tobacco Control (FCTC) is a step in the 
wrong direction.
Occupational health is currently a luxury of  developed 
countries.  South Africa is leading the way in southern 
Africa91 in investigating workplace conditions and 
legislating to protect workers and provide compensation 
for industrial injury.92  In Malawi, such bureaucratic 
efficiency	and	legislative	completeness	are	some	way	off.
Conclusion and research priorities
Malawi has a very large burden of  infectious respiratory 
disease. The common causes of  hospital admission and 
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death are bacterial pneumonia and TB. At least 70% of  
adults with severe respiratory disease and many of  the 
children	 are	 HIV	 infected.	 HIV	 infection	 significantly	
increases incidence and mortality of  pneumonia and TB. 
Malawi also has an unknown burden of  non-infectious 
respiratory disease due to biomass fuel use and the 
tobacco industry.
The research priorities in infectious disease are to design 
effective implementation strategies for the existing 
effective health interventions. There are available 
preventive measures that could markedly reduce the burden 
of  disease which include immunisation with bacterial 
conjugate vaccines, prevention of  HIV infection and 
mother-to-child transmission, cotrimoxazole prophylaxis 
and isoniazid preventive therapy. The challenges are 
effective implementation and lack of  resources. The 
research	priorities	in	non-infectious	disease	are	to	define	
the health effects of  biomass fuel use and the tobacco 
industry.
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